U.S. Machinery Stock News

NasdaqGS:AVPT
NasdaqGS:AVPTSoftware

Exploring High Growth Tech Stocks In The US December 2025

As the U.S. stock market continues to reach new heights, with major indices like the S&P 500 setting all-time records, investor sentiment remains buoyant despite recent volatility in tech shares. In this thriving environment, identifying high growth tech stocks involves looking for companies that not only show robust revenue potential but also demonstrate resilience and adaptability amid shifting economic landscapes.
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Three Companies Estimated To Be Trading Below Their Intrinsic Value

As the U.S. stock market continues to reach new heights, with major indices like the S&P 500 setting all-time records, investors are increasingly looking for opportunities that may be overlooked in this bullish environment. In such a climate, identifying stocks trading below their intrinsic value can offer potential avenues for growth and diversification amidst the prevailing optimism.
NYSE:HNGE
NYSE:HNGEHealthcare

Insider Confidence In December 2025's Leading Growth Companies

As the U.S. stock market continues to reach new heights, with the S&P 500 setting an all-time high and major indices logging consecutive gains, investors are increasingly attracted to companies that demonstrate robust growth potential and strong insider confidence. In this thriving environment, stocks with high insider ownership often signal a deep commitment from those who know the company best, suggesting alignment with shareholder interests and potential resilience in times of market...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

3 Dividend Stocks To Consider With Yields Up To 4.6%

As the U.S. stock market continues to reach new heights, with major indices like the S&P 500 setting all-time records, investors are increasingly looking for stability and income in a dynamic environment. In this context, dividend stocks offer an attractive proposition by providing regular income streams and potential for capital appreciation, making them a compelling option amid the current market momentum.
NasdaqCM:RZLT
NasdaqCM:RZLTBiotechs

Rezolute (RZLT) Valuation Revisited After Phase 3 sunRIZE Trial Misses Primary and Key Secondary Endpoints

Rezolute (RZLT) just released topline data from its pivotal Phase 3 sunRIZE trial in congenital hyperinsulinism, and the drug missed both primary and key secondary endpoints, forcing investors to quickly reassess the story. See our latest analysis for Rezolute. The setback helps explain why Rezolute’s 30 day share price return sits at around negative 72 percent even after a sharp short term rebound. The share price closed at 2.74 dollars, and while the three year total shareholder return is...
NYSE:CC
NYSE:CCChemicals

Is Chemours A Bargain After PFAS Headwinds And A 55% Three Year Share Price Slide?

Wondering whether Chemours at around $12 is a bargain or a value trap? You are not alone, and this breakdown is designed to help you decide with a clear, valuation-first lens. Despite a tough longer-term picture, with the stock still down 29.0% over the past year and 55.1% over three years, it has shown some short-term life, rising 3.4% in the last week and 4.3% over the past month, even though it remains down 28.2% year to date. Recent moves have been shaped by ongoing headlines around...